EliA™ autoimmunity assays
Improve patient outcomes with autoimmune diagnostic confidence
Patients deserve optimized symptom management. You deserve the diagnostic confidence to deliver it. Trusted and accurate results you’d expect from one of the global leaders in autoimmunity diagnostics.
For laboratorians interested in EliA tests, explore the EliA product catalog.
The answer to autoimmune disease uncertainty
Overlapping autoimmune disease symptoms, especially during early onset, can make diagnosing by symptoms alone very difficult.1
EliA autoimmunity assays are the solution you’re looking for.
With an optimized balance of specificity and sensitivity, EliA assays help healthcare providers gain additional insight used to support disease-specific diagnoses and optimize patient management.
A comprehensive autoimmunity testing menu
EliA diagnostics comprise an ever-growing portfolio of more than 50 clinically relevant tests for autoimmune diseases. Learn more about disease states and EliA testing.
Learn more about disease states
Why does specificity matter?
It’s all about avoiding false-positive results and reducing unnecessary follow-up testing.
Why choose EliA autoimmune diagnostics?
Dependable results, diagnostic confidence, and optimized speed to diagnosis equates to enhanced patient outcomes.
Diagnostic confidence
Autoimmune diseases can be difficult to diagnose. EliA tests help identify specific markers to aid in their diagnoses.
Speed to diagnosis
Some EliA tests can help speed diagnoses by detecting autoantibodies early in the disease stage—possibly before symptom onset.2
Continuous innovation
Phadia AB, manufacturer of EliA assays, has provided continuous innovation in autoimmune testing for more than 20 years.
Dependable results
Reliable results can help estimate disease severity and prognosis.3-4
Why should laboratories offer EliA autoimmunity diagnostics?
Run on our scalable, fully automated Phadia™ Laboratory Systems, EliA tests provide reliable results you can trust.
Professional and efficient laboratory support
Rely on our industry leading service and support, which are paired with rapid response times.
Comprehensive testing suite
Offer healthcare providers one of the broadest testing portfolios on the market.
Fewer verification steps
Increase laboratory efficiencies thanks to our high-volume lots with excellent lot-to-lot reproducibility, optimal accuracy, and quality antigens.
Maximized time and workflow
Save time and optimize efficiency with a unique calibration system (with one calibration curve per method stored for 28 days) and ready-to-use reagents.
Contact our experts to learn more about EliA tests and Phadia Laboratory Systems.
Frequently asked questions
Almost any provider, including both general healthcare providers and specialists, can order a test (assuming the laboratory of choice offers EliA tests).
Follow typical ordering procedures just as you would for any other blood test and select a laboratory that offers EliA tests.
Results should be interpreted according to local guidelines and in conjunction with the patient’s clinical examination and symptom history. For more information, contact your local expert.
Take a deep dive via our product catalog or contact an expert with additional questions.
Contact our experts to purchase EliA tests. Note, however, that you’ll need Phadia Laboratory Systems to run both EliA autoimmunity assays and other tests such as ImmunoCAP allergy diagnostics.
For additional info on EliA tests, autoimmune diseases, and/or educational tools and resources, contact our experts.
Resources
Whether you’re a healthcare provider or laboratorian, Thermo Fisher Scientific offers valuable resources geared to your specific needs.
These products may not be cleared for use in your country. Please contact your sales representative for information about specific product availability.
- Thermo Fisher Scientific. Data on file.
- Werkstetter KJ, Korponay-Szabo IR, Popp A, Villanacci V, Salemme M, Heilig G, et al. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice. Gastroenterology. 2017;153(4):924-35.
- Mathsson Alm L, Fountain DL, Cadwell KK, Madrigal AM, Gallo G, Poorafshar M. The performance of anti-cyclic citrullinated peptide assays in diagnosing rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol. 2018;36(1):144-52.
- Mascialino B, Swiniarski S, Gehring I., Poorafshar M, Tarrant T. Serum Autoantibody Multi-Analyte Testing in Rheumatoid Arthritis Can Reduce Avoidable Costs Associated from False Positive Results. A Simulation Study in the United States of America. Presented at ACR Annual Meeting Chicago. 19-24 October 2018.
- Robier C, Amouzadeh-Ghadikolai O, Stettin M, Reicht G. Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on Hep-2 cells. Clin Chem Lab Med. 2016;54(8):1365-70.
- Willems P, De Langhe E, Claessens J, Westhovens R, Van Hoeyveld E, Poesen K, et al. Screening for connective tissue disease-associated antibodies by automated immunoassay. Clin Chem Lab Med. 2018;56(6):909-18.
- Schmitt J, Papisch W. Recombinant autoantigens. Autoimmun Rev. 2002;1(1-2):79-88
